Tag: the war on (some) drugs

The Feds Who Made America’s Fentanyl Freakout Worse

Police officers in Texas were told some terrifying news on June 26, 2018: Anti-government flyers poisoned with a deadly opioid had been placed on Harris County Sheriff’s Office squad cars, and a sergeant who had touched one was en route to the hospital with overdose symptoms. The incident set off a flurry of media coverage, and it frightened police halfway across the country. The Maine Information Analysis Center forwarded Harris County’s bulletin to local departments, while the Commonwealth Fusion Center wrote its own safety alert for Massachusetts officers.

But it wasn’t true. Three days later, a laboratory analysis found that there was no fentanyl on the flyers. The Harris County Sheriff’s Office blamed the panic on a problem with field test kits.

Fentanyl, a synthetic opioid hundreds of times more powerful than morphine, is responsible for about half of overdose deaths in the United States. Among law enforcement, it has taken on mythical properties. First responders around the country have claimed to have nearly died from accidental exposure, based on the scientifically inaccurate idea that a deadly amount of fentanyl can pass through human skin or even poison the air around it.

That myth has spread through a surprising avenue: America’s counterterrorism agencies.

Leaked police documents reviewed by Reason show that fusion centers—local liaison offices set up by the Department of Homeland Security in the wake of 9/11—have circulated fentanyl myths, causing police officers to panic and wasting first responders’ time.

The documents were first released as part of BlueLeaks, a massive trove of law enforcement data leaked by the hacker collective Anonymous. Out of 121 fentanyl-related bulletins in the BlueLeaks trove reviewed by Reason, at least 36 claimed that fentanyl could be absorbed through the skin and at least 41 discussed the alleged danger of airborne fentanyl.

FBI officials even claimed that fentanyl is “very likely a viable option” for a chemical terrorist attack in a September 2018 bulletin, although they also admitted that there is “no known credible threat reporting” suggesting that anyone was actually planning such an attack.

The more the myths spread, the more officers in the field panicked, convinced that they had fallen victim to an accidental fentanyl overdose.

Fentanyl is a genuinely dangerous drug. A state trooper in Salem County, New Jersey, fainted and had to be revived with naloxone in September 2018 during a drug bust, according to a bulletin by the New Jersey Regional Operations and Intelligence Center. The officer had touched their face with fentanyl-contaminated hands—likely bringing the drug into contact with the mouth or eyes—and later tested positive for opioid exposure.

But overdosing “from transdermal and airborne exposure to Illicitly Manufactured Fentanyl (IMF) is a near scientific impossibility,” according to the Harm Reduction Coalition.

In other words, fentanyl can’t jump through air or the skin to suddenly kill you.

Keep reading

New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages

Few people know that new prescription drugs have a 1 in 5 chance of causing serious reactions after they have been approved. That is why expert physicians recommend not taking new drugs for at least five years unless patients have first tried better-established options, and have the need to do so.

Few know that systematic reviews of hospital charts found that even properly prescribed drugs (aside from misprescribing, overdosing, or self-prescribing) cause about 1.9 million hospitalizations a year. Another 840,000 hospitalized patients are given drugs that cause serious adverse reactions for a total of 2.74 million serious adverse drug reactions. About 128,000 people die from drugs prescribed to them. This makes prescription drugs a major health risk, ranking 4th with stroke as a leading cause of death. The European Commission estimates that adverse reactions from prescription drugs cause 200,000 deaths; so together, about 328,000 patients in the U.S. and Europe die from prescription drugs each year. The FDA does not acknowledge these facts and instead gathers a small fraction of the cases.

Perhaps this is “the price of progress”? For example, about 170 million Americans take a prescription drug, and many benefit from the drug. For some, drugs save their life or keep them alive. About 80 percent of them are generic; that is to say, drugs whose benefits and risks are better known. If we suppose they all benefit, then 2.7 million severe reactions is only about 1.5 percent.

But as far as we can tell (very little research is funded on prescription drugs as a health risk compared to less deadly risks like diabetes or Alzheimer’s disease), millions who take new, patented drugs experience only modest benefits over established drugs. Only a small percent of new drugs provide significant advantages for patients to offset these risks of harm. Independent reviews over the past 35 years have found that only 11 to 15 percent of newly approved drugs have significant clinical advantages over existing, better-known drugs. These contribute to the large medicine chest of effective drugs developed over the decades. But the 85 to 89 percent with little or no clinical advantage flood the market. About four-fifths of the additional $70 billion spent on drugs since 2000 in the U.S. (and another $70 billion abroad) have been spent on these minor new variations rather than on the really innovative drugs.

Keep reading

USC researchers think THC in marijuana may be able to treat deadly COVID complication

Top University of South Carolina researchers think the chemical in marijuana that induces a “high” may be effective in treating a potentially lethal coronavirus complication, according to three newly released studies

The studies, co-published by Prakash Nagarkatti, found THC, the most potent mind-altering chemical in cannabis, can — in mice — prevent a harmful immune response that causes Acute Respiratory Distress Syndrome (ARDS) and cause a significant increase in healthy lung bacteria.

The studies, published in Frontiers in Pharmacology, the British Journal of Pharmacology and the International Journal of Molecular Sciences, were conducted by giving mice a toxin that triggered the harmful immune reaction that causes ARDS and then injecting mice with THC, according to the studies’ abstracts.

“The underlying mechanism is your immune system goes haywire and starts destroying your lungs and all your other organs,” Nagarkatti said of ARDS.

“Its’ like a car where you’re putting on a lot of accelerator, but the brakes aren’t working,” Nagarkatti said. “Basically what’s going to happen is your car is going to crash because you can’t stop it. And that’s basically what’s happening with ARDS.”

Keep reading

House to vote on removing cannabis from list of controlled substances

The House will vote on legislation next month to remove cannabis from the Controlled Substances Act and erase some marijuana criminal records. 

The bill would not legalize the drug, which would be left up to states, but the vote will still be a historic step in the effort to reduce legal penalties related to the drug. House Majority Whip James Clyburn (D-S.C.) said in an email to members that the vote will take place during the September work period.

Keep reading